Interleukin‐22 in urinary tract disease – new experimental directions - Institut Pasteur Access content directly
Journal Articles Clinical and Translational Immunology Year : 2020

Interleukin‐22 in urinary tract disease – new experimental directions

Abstract

Interleukin (IL)-22 is expressed by immune cells in the urinary tract and IL-22 receptor is expressed in urothelium and renal tubule cells. IL-22 can be specifically targeted in the urinary tract or conditionally depleted in mice and targeted therapeutically in humans.

Domains

Immunology
Fichier principal
Vignette du fichier
Interleukin22 in urinary tract disease.pdf (302.27 Ko) Télécharger le fichier
Origin : Publication funded by an institution
Loading...

Dates and versions

pasteur-02899702 , version 1 (15-07-2020)

Licence

Attribution

Identifiers

Cite

Molly A Ingersoll, Malcolm Starkey. Interleukin‐22 in urinary tract disease – new experimental directions. Clinical and Translational Immunology, 2020, 9 (6), pp.e1143. ⟨10.1002/cti2.1143⟩. ⟨pasteur-02899702⟩

Collections

PASTEUR
20 View
62 Download

Altmetric

Share

Gmail Facebook X LinkedIn More